The Use of Genomics to Drive Kidney Disease Drug Discovery and Development

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.11070919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

The Use of Minipig in Drug Discovery and Development

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2015English

Application of Genomics and Proteomics in Drug Target Discovery

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Skill, Drive and Luck: The Discovery and Development of Heparin

CMAJ
Medicine
2011English

Drug-Related Disease and the Kidney.

BMJ
1979English

Genetic Basis of Kidney Cancer: Role of Genomics for the Development of Disease-Based Therapeutics

Genome Research
Genetics
2012English

Drug Discovery and Development: The Final Frontier

Prescriber
Pharmacology
2020English

Importance and Hurdles to Drug Discovery for Neurological Disease

Annals of Neurology
Neurology
2013English

Mycobacterial Genomics and Structural Bioinformatics: Opportunities and Challenges in Drug Discovery

Emerging Microbes and Infections
ImmunologyVirologyMicrobiologyEpidemiologyParasitologyMedicineDrug DiscoveryInfectious Diseases
2019English

Erratum To: Genomics-Guided Precise Anti-Epileptic Drug Development

Neurochemical Research
MedicineBiochemistryCellularMolecular Neuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy